X

Vous n'êtes pas connecté

Maroc Maroc - ELECTRICIANSFORUMS.NET - Ala Une - 18/Jan 18:44

3 Phase Supply

Articles similaires

Sorry! Image not available at this time

Vestas secures turbine supply deal for Ukrainian wind project

power-technology.com - 23/Jan 10:53

Vestas has secured an order to supply turbines for the second phase of the Tyligulska project in Ukraine - the country’s largest.

Karnataka to supply continuous power to farmers' homes located in fields

hindustantimes.com - 23/Jan 03:47

At present farmhouses in Karnataka receive seven hours of three-phase electricity, while for the rest of the day, from 6 pm to 6 am.

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

menafocus.qa - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

emiratesnewswire.ae - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

africanewswire.za.com - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

qatarnewswire.qa - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

pressarabia.qa - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...

Sorry! Image not available at this time

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

emiratesnewswire.com  - 12:16

– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in...